New Delhi, February 28: The data from PubMed, a globally recognised database for biomedical and life sciences research, reveals a staggering 376.5% increase in the number of research publications around Giloy (Tinospora cordifolia) over the past decade, highlighting a growing global interest in the plant's therapeutic potential.
On searching the database for studies on ‘guduchi or tinospora cordifolia or amrita’, the results show 243 studies published in 2014. In contrast, in 2024, the number rose to 913, i.e. 376.5% increase.
Tinospora cordifolia, commonly known as Guduchi or Giloy, familiar as Amrita in Sanskrit, which translates to the ‘herb of immortality’, because of its abundant beneficial properties.
Notably, Guduchi is a popular herb known as Giloy and has been used in therapeutics for a long time in Ayush systems. While scientists have long been intrigued by Giloy’s medicinal properties, the years following the COVID-19 pandemic saw a major spike in research as experts explored natural immunity boosters and holistic healthcare solutions. Emerging studies reinforce its immune-modulatory, antiviral, and adaptogenic properties, making it a subject of keen interest among global researchers and healthcare practitioners.
While highlighting the efforts of the Ministry to boost scientific research in Ayush, Secretary, Ministry of Ayush, Vaidya Rajesh Kotecha, stated, "Scientific validation of Ayush formulations, herbs, etc., including medicinal plants like Giloy, is a top priority for the Ministry. We are committed to strengthening research collaborations,funding scientific studies, and promoting evidence-based integration of Ayurveda with mainstream healthcare to benefit global health."
Emphasizing the importance of scientific research and publication, Director General, CCRAS, Prof. Rabinarayan Acharya stated, “Research on medicinal plants is vital for bridging traditional wisdom with modern science. Scientific publications serve as a foundation for evidence-based validation, enhancing global acceptance and integrating Ayurveda into mainstream healthcare.”
The increasing number of clinical studies and laboratory research suggests that Giloy may have a significant role in cancer therapy, autoimmune disease management, and even inflammatory disorders.
Dr Galib, Associate Professor at the All-India Institute of Ayurveda, New Delhi, explains, "Scientific exploration of Giloy is gaining momentum, with increasing studies showcasing its medicinal potential. Recent research highlights its bioactive compounds and therapeutic benefits, including immune-boosting and anti-inflammatory properties. This growing interest positions Giloy as a promising candidate for future clinical applications in various medical fields."
